AR and prostate cancer: Western blotting of androgen receptor (AR)-proficient and -deficient prostate lines confirmed upregulation of ARF6 and IQSEC1 protein expression in metastatic prostate cancer cell lines (LNCaP, VCaP, DU145, PC3) (Fig. 1h).